Discovery Of A Quinoline-Based Senomorphic Agent For The Treatment Of Chronic Kidney Disease
Scientists have made a significant stride in the fight against chronic kidney disease, a condition characterized by the gradual loss of kidney function. Their recent work focuses on a new type of compound, derived from a chemical structure called quinoline, which acts as a “senomorphic agent.” Senomorphic agents work by targeting senescent cells, often called “zombie cells,” which accumulate in tissues with age and disease. These senescent cells stop dividing but remain active, releasing harmful substances that cause inflammation and damage to surrounding healthy cells, contributing to the progression of chronic kidney disease. The newly identified quinoline-based agent aims to modulate the activity of these senescent cells, reducing their detrimental effects without necessarily eliminating them entirely. This approach holds promise for mitigating kidney damage and improving kidney function by addressing a fundamental mechanism of disease progression.
Source: link to paper